Unlike compounded tirzepatide, which lacks regulatory oversight and can vary in quality, these FDA-approved options are rigorously tested, ensuring they meet high standards for weight loss therapy
Walking is a great type of exercise that can help prevent and manage constipation
This approach delivers clinically meaningful weight loss, with many individuals losing over 10% of their body weight within months
However, more research is needed on combining them, as side effects are still possible
Comfort and absorption speed are separate considerations that do not always point the same direction
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Ozempic) and chronic weight management (Wegovy) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities